Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: Results of a randomized trial
Matthias Büchler(Centre Hospitalier Universitaire de Tours), Yvon Lebranchu(Académie Nationale de Médecine), David Ternant(Université de Tours), Florence Herr(Inserm), Gilles Thibault, Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Hélène Longuet(Centre Hospitalier Universitaire de Tours), Philippe Gatault(Centre Hospitalier Universitaire de Tours), Crystal Sung, Djamila Lemay(Sanofi (France)), Christophe Baron(Université de Tours), Roxane Lemoine(Université de Tours), Christine Foulon(Centre Hospitalier Sainte-Anne), Bernadette Pilorge(Centre Hospitalier Universitaire de Tours)
Cited by 29
Related Papers
Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
|American Journal of Transplantation|2002|256
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|228
Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population
|Kidney International|2000|191
Acute Renal Infarction
|Clinical Journal of the American Society of Nephrology|2012|176
Etiology and Outcomes of Thrombotic Microangiopathies
|Clinical Journal of the American Society of Nephrology|2019|167